Advertisement
UK markets open in 1 hour 42 minutes
  • NIKKEI 225

    39,082.00
    +464.90 (+1.20%)
     
  • HANG SENG

    18,912.87
    -282.73 (-1.47%)
     
  • CRUDE OIL

    77.05
    -0.52 (-0.67%)
     
  • GOLD FUTURES

    2,372.60
    -20.30 (-0.85%)
     
  • DOW

    39,671.04
    -201.95 (-0.51%)
     
  • Bitcoin GBP

    54,550.07
    -283.13 (-0.52%)
     
  • CMC Crypto 200

    1,514.48
    -11.94 (-0.78%)
     
  • NASDAQ Composite

    16,801.54
    -31.08 (-0.18%)
     
  • UK FTSE All Share

    4,560.55
    -23.85 (-0.52%)
     

Teva Stock Powers Ahead as Schizophrenia News Offsets Mixed Earnings

Teva Stock Powers Ahead as Schizophrenia News Offsets Mixed Earnings

Shares of Teva Pharmaceutical Industries were climbing yet again on Wednesday, after the company announced positive results in a trial of a schizophrenia medicine. Its quarterly results, also disclosed early Wednesday, were mixed. Revenue was $3.8 billion for the quarter, slightly better than the FactSet consensus estimate of $3.7 billion, while non-GAAP diluted earnings were 48 cents a share.